Iron

erythropoietin ; Homo sapiens







627 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
601 2130296 Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. 1990 1
602 2239935 Bioavailability of iron in hemodialysis patients treated with erythropoietin: evidence for the inhibitory role of aluminum. 1990 Nov 1
603 2239943 The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment. 1990 Nov 1
604 2318987 Hepatic iron in dialysed patients given intravenous iron dextran. 1990 Feb 2
605 2357123 Case management of the anemic patient. Epoetin alfa: focus on iron management. 1990 Jun 3
606 2362636 Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin. 1990 1
607 2382644 Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients. 1990 Aug 3
608 2383057 Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status. 1990 Jun 1
609 2391604 Abnormal iron distribution in infants of diabetic mothers: spectrum and maternal antecedents. 1990 Sep 2
610 2504356 Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. 1989 Jul 15 1
611 2709674 Iron status in patients receiving erythropoietin for dialysis-associated anemia. 1989 Feb 2
612 2754306 Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy. 1989 Aug 3
613 2757026 Iron management during recombinant human erythropoietin therapy. 1989 Aug 1
614 3391030 Effect of erythropoietin on iron kinetics in patients with end-stage renal disease. 1988 1
615 3537801 Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. 1987 Jan 8 1
616 4019471 The regulation of heme biosynthesis during erythropoietin-induced erythroid differentiation. 1985 Aug 5 1
617 6584679 Serum erythropoietin levels in children with chronic renal failure. 1983 Nov 1
618 7153668 A mathematical model of iron metabolism. 1982 1
619 7459282 In vitro assay of erythropoietin in fetal mouse liver cultures. II. Effects of human transferrin bound iron and of serum on the stimulation of incorporation of 3H-thymidine into DNA. 1981 Mar 1
620 6256861 [Polycythaemia and uterine fibroma. A case with in vitro demonstration of an erythropoietic activity in the tumor (author's transl)]. 1980 Jun 18-25 1
621 973651 A complement independent erythropoietic inhibitor acting on the progenitor cell in refractory anemia. 1976 Oct 1
622 5037589 Route of 59 Fe administration as a factor effecting the sensitivity of an erythropoietin bioassay. 1972 Jun 1
623 4173896 [Comparative studies on the erythropoietin activity in patients with polycythemia vera and chronic cardiorespiratory insufficiency by means of the determination of radio-iron (Fe59) incorporation]. 1967 1
624 5588046 [Effect of erythropoietin on the plasma iron transport]. 1967 Mar 1
625 14323195 [THE EFFECT OF ERYTHROPOIETIN CONCENTRATE ON THE IRON INCORPORATION BY NUCLEATED ERYTHROCYTES IN VITRO]. 1964 Nov 1 1
626 14073162 HUMORAL REGULATION OF ERYTHROPOIESIS. XII. EFFECT OF ERYTHROPOIETIN AND IRON ON CELL SIZE IN IRON DEFICIENCY ANEMIA. 1963 Aug-Sep 1
627 13890698 Effect of erythropoietin on the uptake and utilization of iron by bone marrow cells in vitro. 1962 Jul 1